# Appropriate Limit Value for 1 mg DST in Patients With Chronic Renal Failure

> **NCT05568602** · — · COMPLETED · sponsor: **Marmara University** · enrollment: 1034 (actual)

## Conditions studied

- Cushing Syndrome

## Interventions

- **DIAGNOSTIC_TEST:** Dexamethasone suppression test

## Key facts

- **NCT ID:** NCT05568602
- **Lead sponsor:** Marmara University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-01
- **Primary completion:** 2021-06-01
- **Final completion:** 2021-08-01
- **Target enrollment:** 1034 (ACTUAL)
- **Last updated:** 2022-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05568602

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05568602, "Appropriate Limit Value for 1 mg DST in Patients With Chronic Renal Failure". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05568602. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*